Victory Capital Management Inc. raised its holdings in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 402.9% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 179,049 shares of the company's stock after buying an additional 143,446 shares during the period. Victory Capital Management Inc. owned approximately 0.15% of Privia Health Group worth $3,260,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of PRVA. Sequoia Financial Advisors LLC raised its holdings in shares of Privia Health Group by 2.3% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 26,246 shares of the company's stock valued at $478,000 after purchasing an additional 583 shares in the last quarter. Benjamin F. Edwards & Company Inc. lifted its holdings in shares of Privia Health Group by 8.5% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 7,695 shares of the company's stock worth $134,000 after purchasing an additional 605 shares during the period. Arizona State Retirement System boosted its holdings in shares of Privia Health Group by 2.4% in the second quarter. Arizona State Retirement System now owns 26,574 shares of the company's stock valued at $462,000 after acquiring an additional 617 shares in the last quarter. Signaturefd LLC increased its position in Privia Health Group by 46.3% during the 2nd quarter. Signaturefd LLC now owns 1,978 shares of the company's stock worth $34,000 after purchasing an additional 626 shares during the period. Finally, Parkside Financial Bank & Trust lifted its holdings in shares of Privia Health Group by 9.7% in the 2nd quarter. Parkside Financial Bank & Trust now owns 8,684 shares of the company's stock valued at $151,000 after buying an additional 771 shares during the period. 94.48% of the stock is currently owned by hedge funds and other institutional investors.
Privia Health Group Price Performance
PRVA stock traded up $0.48 during midday trading on Friday, reaching $21.56. 608,688 shares of the company's stock traded hands, compared to its average volume of 910,648. Privia Health Group, Inc. has a fifty-two week low of $15.92 and a fifty-two week high of $24.30. The business has a 50-day moving average price of $18.96 and a two-hundred day moving average price of $18.57. The company has a market capitalization of $2.59 billion, a P/E ratio of 215.60, a PEG ratio of 5.26 and a beta of 0.76.
Wall Street Analyst Weigh In
A number of equities research analysts have commented on PRVA shares. Truist Financial raised their target price on Privia Health Group from $24.00 to $27.00 and gave the company a "buy" rating in a report on Friday, November 8th. Robert W. Baird lifted their price target on shares of Privia Health Group from $23.00 to $24.00 and gave the company an "outperform" rating in a research report on Monday, August 26th. Royal Bank of Canada restated an "outperform" rating and issued a $28.00 price target on shares of Privia Health Group in a report on Wednesday, August 14th. Barclays boosted their target price on Privia Health Group from $19.00 to $21.00 and gave the stock an "equal weight" rating in a research report on Friday, November 8th. Finally, KeyCorp assumed coverage on Privia Health Group in a research report on Friday, October 11th. They set an "overweight" rating and a $23.00 price objective for the company. Two equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, Privia Health Group currently has a consensus rating of "Buy" and an average target price of $25.07.
Get Our Latest Research Report on Privia Health Group
Insider Buying and Selling at Privia Health Group
In other news, CEO Parth Mehrotra sold 135,142 shares of the business's stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the transaction, the chief executive officer now directly owns 247,771 shares of the company's stock, valued at approximately $4,583,763.50. The trade was a 35.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 14.20% of the stock is currently owned by corporate insiders.
Privia Health Group Company Profile
(
Free Report)
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Further Reading
Before you consider Privia Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.
While Privia Health Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.